Jul 2026· Indian drugs· Vol 63, pp. 47-53· 0 citations· 9 references
TL;DR
F Forced degradation studies indicated that valbenazine was susceptible to alkaline hydrolytic conditions, and was relatively stable under the other stress conditions, and was relatively stable under the other stress conditions.
Abstract
Valbenazine tosylate is a drug indicated for the management of tardive dyskinesia. This study presents the optimization of chromatographic methods to assess the inherent stability of this molecule. The stability studies were executed as per the ICH guidelines, integrating multiple stress conditions that involved hydrolytic conditions with pH variation, oxidative, photolytic, and thermal degradation. An HPTLC system from CAMAG was used, utilizing silica gel 60 F254 plates. The mobile phase was a mixture of toluene and methanol in a 7:3 volume ratio. Detector was set at 280 nm. An HPLC system included a pump (PU 2080 Plus) and PDA detector (MD 2010 Plus). Acetonitrile and acetate buffer pH 5 were used as the optimized phase. ICH Q2 (R1) guideline was referred to validate the optimized methods. Forced degradation studies indicated that valbenazine was susceptible to alkaline hydrolytic conditions, and was relatively stable under the other stress conditions.
These proposed separation strategies showed high specificity, substantiating clear resolution of DMG foreign substance by the drug compound, also with foreign substances, and confirmed the method’s suitability for both regulatory compliance and routine application in industrial Quality Control laboratories.
M. Srinivas, B. Andrews, V. D. N. Kumar Abbaraju et al.· RASAYAN Journal of Chemistry· 0 citations
A stability-indicating HPLC method was developed and validated for the simultaneous determination of sulfadimethoxine (SDM) and ormetoprim (OMP) in an oral solution. Chromatographic separation was achieved on a C18 column using 0.05% (v/v) phosphoric acid in water and methanol as the mobile phase under gradient elution...
A reliable, innovative and stability-indicating HPTLC method was developed and validated for estimating inosine pranobex (IP) in both bulk drug and pharmaceutical formulations using a Quality by Design (QbD) approach to achieve systematic optimization.
Simran M. Jamadar, Priyanka G. Kale, Kumudini Pawar· Indian drugs· 0 citations
Objective: To develop and validate an analytical quality by design (AQbD) guided stability indicating high-performance liquid chromatography (HPLC) method for the estimation of meloxicam in bulk drug and tablet formulations.
Methods: A systematic AQbD approach was employed using Box–Behnken Design (BBD) to evaluate the...
Liladhar Marathe, Shital Patel, Minal Salunkhe et al.· International Journal of App...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.